Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : CardioDynamics (CDIC) -- Ignore unavailable to you. Want to Upgrade?

To: David Wiggins who wrote (67)	8/26/1999 4:00:00 PM
From: David Wiggins	Read Replies (1) \| Respond to of 201

GE MARQUETTE MEDICAL SYSTEMS AND CARDIODYNAMICS INTERNATIONAL Business Wire August 26, 1999, 9:29 a.m. PT Announce Strategic Alliance; GE Marquette Commits to Initial BioZ.com Purchase of $714,000 Business Editors/Health & Medical Writers European Congress of Cardiology MILWAUKEE and SAN DIEGO--(BW HealthWire)--Aug. 26, 1999--GE Marquette Medical Systems and CardioDynamics International Corp. (Nasdaq:CDIC), today announced a strategic alliance between the companies. The alliance provides GE Marquette exclusive rights to market and sell CardioDynamics' BioZ(R) noninvasive digital cardiac output monitoring systems to hospitals in select European countries, including France, Germany, Belgium, Netherlands, and Luxembourg. Additionally, the alliance provides for further avenues of cooperation, including technology integration. Under the terms of the agreement, GE Marquette will initially purchase $714,000 of BioZ.com Systems and accessories to launch its European sales effort. The companies will be jointly exhibiting the BioZ System at the XXIst European Congress of Cardiology August 28 - September 1, 1999 in Barcelona, Spain. "The BioZ monitoring system answers our customer's needs for an accurate and noninvasive assessment of cardiovascular function and complements our overall corporate commitment to reducing costs while maintaining quality patient care," said Gary Close, vice president of Global Marketing, GE Marquette Medical Systems. "GE Marquette has launched a very progressive cardiology management program called CardioIntelligence, that aggregates the many different data types used for the comprehensive management of the cardiology patient. The BioZ system will provide an important and new set of clinical data for a more complete view." Michael K. Perry, chief executive officer of CardioDynamics, stated, "Our alliance with GE Marquette will facilitate tremendous access to their monitoring and cardiology product platforms and also will enable us to reach a significantly expanded number of European customers with our noninvasive cardiac function monitoring technology. The initial commitment of $714,000 for Europe is sizeable to CardioDynamics and the partnership is anticipated to significantly boost future sales." Perry added, "This alliance builds on CardioDynamics' expertise in noninvasive monitoring technology and rapid product development, as well as GE Marquette's recognized position in medical diagnostic and monitoring equipment to hospitals. GE Marquette has global market presence and offers great potential to accelerate the use of noninvasive hemodynamic monitoring. We believe this relationship with GE Marquette will help establish the BioZ's measurement capabilities as the Sixth Vital Sign(TM)." CardioDynamics, with headquarters in San Diego, is committed to fundamentally changing the way hemodynamic monitoring is performed in healthcare. The Company's primary products, the BioZ(R) System, Portable BioZ(TM) and BioZ.com(TM), utilize its proprietary Thoracic Electrical Bioimpedance (TEB) technology to noninvasively obtain data on a wide range of hemodynamic parameters. The worldwide market potential for the BioZ(R) products is estimated to be $4 billion, together with an additional $800 million in recurring annual revenue for disposables. For additional information, please refer to the company's Web site at www.cardiodynamics.com. GE Marquette Medical Systems is a leading global provider of medical diagnostic equipment and services including diagnostic cardiology, patient monitoring and clinical information systems. GE Marquette, a GE Medical Systems Co., is headquartered in Milwaukee. Additional information about GE Marquette and its products can be found on the company's web site at mei.com. GE Medical Systems is a $6 billion business, employing nearly 20,000 people worldwide.